Alexander Zider

ORCID: 0000-0002-1535-7315
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease and Transplantation
  • Sepsis Diagnosis and Treatment
  • Cardiac tumors and thrombi
  • Drug-Induced Hepatotoxicity and Protection
  • Protein purification and stability
  • Electrocatalysts for Energy Conversion
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Immune Response and Inflammation
  • Liver Disease Diagnosis and Treatment
  • Pulmonary Hypertension Research and Treatments
  • Healthcare Policy and Management
  • Asthma and respiratory diseases
  • Monoclonal and Polyclonal Antibodies Research
  • Fuel Cells and Related Materials
  • Electrolyte and hormonal disorders
  • Soft tissue tumor case studies
  • Emergency and Acute Care Studies
  • Patient Safety and Medication Errors
  • Biosimilars and Bioanalytical Methods
  • Medical Imaging and Pathology Studies
  • IgG4-Related and Inflammatory Diseases
  • Inflammation biomarkers and pathways
  • Respiratory and Cough-Related Research
  • Vascular Anomalies and Treatments

Mills Peninsula Health Services
2021

Pulmonary Associates
2021

University of California, Los Angeles
2011-2017

VA Greater Los Angeles Healthcare System
2015

UCLA Medical Center
2013

Tufts University
2010

Pulmonary tumor thrombotic microangiopathy (PTTM) is a disease process wherein cells are thought to embolize the pulmonary circulation causing hypertension (PH) and death from right heart failure. Presented herein clinical, laboratory, radiographic, histologic features across seven cases of PTTM. Highlighted in this publication also involvement venules clinical distinguishing PTTM mimics. We conducted retrospective chart review hospitals greater Los Angeles metropolitan area. Patients series...

10.1177/2045893217728072 article EN cc-by-nc Pulmonary Circulation 2017-08-01

With the rapid growth of monoclonal antibody-based products, new technologies have emerged for creating modified forms antibodies, including fragments, conjugates and multi-specific antibodies. We created a database 450 therapeutic antibodies in development to determine which indications will constitute "next generation" antibody products. conclude that future closely resemble already been approved commercial sale.

10.4161/mabs.12461 article EN mAbs 2010-07-01

Patients with acute liver failure have high rates of infections, likely from defects in immune function. Whether infections are independently associated poor outcomes is unclear. We hypothesized that patients injury who developed were at increased risk adverse outcomes.We conducted a retrospective analysis 150 critically ill adult admitted dysfunction single academic institution between 2005 and 2011. excluded immunocompromised states, chronic disease died or discharged within 48 h...

10.1111/liv.13073 article EN Liver International 2016-01-23

10.1016/j.ddmod.2011.09.001 article EN Drug Discovery Today Disease Models 2011-10-23

Significant resources have been allocated to decreasing the number of preventable deaths in hospitals, but identifying factors and then leveraging them effect system-wide change remains challenging.To determine ability a novel in-person, multidisciplinary "rapid mortality review" process identify that are action items lead improvements care.Rapid review sessions were conducted weekly for patients who died medical intensive care unit. Patient data clinician opinions regarding discussed...

10.4037/ajcc2021829 article EN American Journal of Critical Care 2021-03-01

In this narrative medicine essay, a pulmonologist learns about process improvement from his father, an engineer, who drew up list of 50 improvements he noted during hospitalizations for prostate cancer.

10.1001/jama.2021.4885 article EN JAMA 2021-04-20
Coming Soon ...